Tinavi Medical Technologies Co.,Ltd.

SHSE:688277 Stock Report

Market Cap: CN¥5.4b

Tinavi Medical TechnologiesLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jin Xu

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.07%
Management average tenureno data
Board average tenure6.1yrs

Recent management updates

Recent updates

Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 45% Share Price Surge Not Quite Adding Up

Feb 24
Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 45% Share Price Surge Not Quite Adding Up

More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Jan 09
More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Would Tinavi Medical TechnologiesLtd (SHSE:688277) Be Better Off With Less Debt?

Dec 05
Would Tinavi Medical TechnologiesLtd (SHSE:688277) Be Better Off With Less Debt?

What Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 60% Share Price Gain Is Not Telling You

Oct 09
What Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) 60% Share Price Gain Is Not Telling You

Is Tinavi Medical TechnologiesLtd (SHSE:688277) A Risky Investment?

Jun 14
Is Tinavi Medical TechnologiesLtd (SHSE:688277) A Risky Investment?

More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

Apr 21
More Unpleasant Surprises Could Be In Store For Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Shares After Tumbling 26%

There's Reason For Concern Over Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Massive 25% Price Jump

Mar 06
There's Reason For Concern Over Tinavi Medical Technologies Co.,Ltd.'s (SHSE:688277) Massive 25% Price Jump

Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

Feb 27
Health Check: How Prudently Does Tinavi Medical TechnologiesLtd (SHSE:688277) Use Debt?

CEO

Jin Xu (50 yo)

no data
Tenure
CN¥1,332,300
Compensation

Mr. Jin Xu serves as the General Manager and Director of TINAVI Medical Technologies Co., Ltd.


Board Members

NamePositionTenureCompensationOwnership
Jin Xu
GM & Directorno dataCN¥1.33m0.071%
CN¥ 3.8m
Min Ma
President & Directorno dataCN¥4.82mno data
Yang Xu
Independent Director1.7yrsCN¥40.00kno data
Ruijun Zhang
Independent Director1.7yrsCN¥40.00kno data
Changjiu Dai
Independent Director6.1yrsCN¥90.00kno data
Dequan Zhu
Director14.6yrsno datano data
Zhi Xiao
Director6.5yrsno datano data
Songgen Zhang
Chairman14.6yrsCN¥1.34m16.77%
CN¥ 909.5m
Binbin Wang
Director9.3yrsno data0.024%
CN¥ 1.3m
Guangzhi Wang
Independent Director6.1yrsCN¥90.00kno data
Zhaoqi Zhu
Supervisor4.7yrsno datano data
Chi Yung Lee
Independent Director1.7yrsCN¥40.00kno data
6.1yrs
Average Tenure
57yo
Average Age

Experienced Board: 688277's board of directors are considered experienced (6.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 09:17
End of Day Share Price 2025/05/22 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tinavi Medical Technologies Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.